Abstract:Cisplatin belongs to platinum-based drugs and is widely used in cancer chemotherapy. Ototoxicity is one of the major dose limiting side-effects of cisplatin. For toxicity to occur cisplatin must first be transported from the bloodstream into cochlear cells. Three copper transporters are considered pathways for regulating the uptake and translocation of cisplatin into cells: Ctr1, ATP7A and ATP7B. Our recent study with cochlear organotypic cultures shows that cochlear hair cells can be destroyed by cisplatin at low concentrations from 10μm to 100μn. However, high doses of cisplatin cannot damage hair cells, maybe due to intrinsic feedback reactions that increase export of platinum by ATP7B when the platinum concentration is high in extracellular space. Cimitidine is a specific copper transporter inhibitor that can block the entrance of copper and platinum, and may prevent cisplatin-induced cochlear hair cell injury. To evaluate this hypothesis, we treated cochlear organotypic cultures with cisplatin (10 μm or 50 μm) alone, or cisplatin combined with cimitidine at concentrations ranging from 10-2000 μm for 48 hours. cisplatin at 10 μm damaged about 20% hair cells. In contrast, when cimitidine (10 μm, 100 μm and 2000 μm) was added to the culture, near 100% cochlear hair cell survived. At higher concentration (50 μm), cisplatin destroyed about 80% of cochlear hair cells. However, 100 μmcimitidine rescued about 50% hair cells from cisplatin damage, and 2000μm cimitidine protected about 80% hair cells. The data of western blot showed that CTR1 and ATP7B expressions were increased in cisplatin treated cochlear tissue, but cimitidine significantly reduced CTR1 and ATP7B. In addition, ATP7A expression was depressed a little after cisplatin treatment. Considering that Ctr1 is involved in copper and platinum influx, but the ATP7A and ATP7B are copper export transporters, the results suggest that cimitidine can effectively block the entrance by copper transporters and stop the influx of cisplatin.

Low, but Not High, Doses of Cisplatin Damage Cochlear Hair Cells in C57 Mouse Organotypic Cultures.

Cisplatin-Induced Damage of C57 Mice Hair Cells in Cochlear Organizational Cultures

Cisplatin-induced vestibular hair cell lesion-less damage at high doses

Modulation of Copper Transporters in Protection Against Cisplatin-Induced Cochlear Hair Cell Damage

Early Physiological and Cellular Indicators of Cisplatin-Induced Ototoxicity

Cisplatin induces damage of auditory cells: Possible relation with dynamic variation in calcium homeostasis and responding channels

Cisplatin drives mitochondrial dysregulation in sensory hair cells

The Mechanotransduction Channel and Organic Cation Transporter Are Critical for Cisplatin Ototoxicity in Murine Hair Cells

Hearing loss when taking cisplatin, depending on the dose

Effectiveness of different approaches for establishing cisplatin-induced cochlear lesions in mice.

Susceptibility of mouse cochlear hair cells to cisplatin ototoxicity largely depends on sensory mechanoelectrical transduction channels both Ex Vivo and In Vivo

Effect of Cisplatin on Morphology and Expression of Bcl-2 Protein in Guinea Pig Cochlea

Overexpression of XIAP Inhibits Cisplatin-Induced Hair Cell Loss.

Cisplatin Damage to the Cochlear Hair Cell of Guinea Pigs

Supporting cells as a target of cisplatin-induced inner ear damage: therapeutic implications

Establishment of sensorineural deafness model in C57 mice by cisplatin

Calpain Mediated Cisplatin-Induced Ototoxicity in Mice.

Kinesin spindle protein inhibitor exacerbates cisplatin-induced hair cell damage

Inhibition of DHCR24 Increases the Cisplatin-Induced Damage to Cochlear Hair Cells in Vitro.

Cisplatin Induces Calcium Ion Accumulation and Hearing Loss by Causing Functional Alterations in Calcium Channels and Exocytosis.

Comparison of Cochlear Cell Death Caused by Cisplatin, Alone and in Combination with Furosemide